{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:42:10Z","timestamp":1788576130986,"version":"build-2803163510"},"reference-count":33,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013348","name":"Innosuisse - Schweizerische Agentur f\u00fcr Innovationsf\u00f6rderung","doi-asserted-by":"publisher","award":["25836.1 PFLS-LS"],"award-info":[{"award-number":["25836.1 PFLS-LS"]}],"id":[{"id":"10.13039\/501100013348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Leishmania major (L. major) causes cutaneous leishmaniasis in the Old World. The infection mostly induces a localized lesion restricted to the sand fly bite. The costs and the side effects of current treatments render imperative the development of new therapies that are affordable and easy to administrate. Topical treatment would be the ideal option for the treatment of cutaneous leishmaniasis. MF29 is a 3-haloacetamidobenzoate that was shown in vitro to inhibit tubulin assembly in Leishmania. Here, we tested a topical cream formulated with MF29. BALB\/c mice were infected in the ear dermis with L. major metacyclic promastigotes and once the lesion appeared, mice were treated with different concentrations of MF29 and compared to the control group treated with the cream used as the vehicle. We observed that topical application of MF29 reduced the progression of the infection while control groups developed an unhealing lesion that became necrotic. The treatment decreased the type 2 immune response. Comparison with SinaAmphoLeish, another topical treatment, revealed that MF29 treatment once a day was sufficient to control lesion development, while application SinaAmphoLeish needed applications twice daily. Collectively, our data suggest that MF-29 topical application could be a promising topical treatment for cutaneous leishmaniasis.<\/jats:p>","DOI":"10.3390\/microorganisms8111803","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T07:23:28Z","timestamp":1605597808000},"page":"1803","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of a New Topical Treatment for the Control of Cutaneous Leishmaniasis"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4124-9104","authenticated-orcid":false,"given":"Berenice","family":"Mart\u00ednez-Salazar","sequence":"first","affiliation":[{"name":"Department of Biochemistry, University of Lausanne, 1066 Epalinges, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Carregaro Pereira","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Lausanne, 1066 Epalinges, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazmin","family":"Hauyon-La-Torre","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Lausanne, 1066 Epalinges, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Khamesipour","sequence":"additional","affiliation":[{"name":"Centre for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran 14166, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3561-0207","authenticated-orcid":false,"given":"Fabienne","family":"Tacchini-Cottier","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Lausanne, 1066 Epalinges, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Alvar, J., V\u00e9lez, I.D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., and Boer, M.D. (2012). Who Leishmaniasis Control the WHO Leishmaniasis Control Team Leishmaniasis Worldwide and Global Estimates of Its Incidence. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0035671"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Bennis, I., De Brouwere, V., Belrhiti, Z., Sahibi, H., and Boelaert, M. (2018). Psychosocial burden of localised cutaneous Leishmaniasis: A scoping review. BMC Public Health, 18.","DOI":"10.1186\/s12889-018-5260-9"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Bailey, F., Mondragon-Shem, K., Haines, L.R., Olabi, A., AlOrfi, A., Ruiz-Postigo, J.A., Alvar, J., Hotez, P., Adams, E.R., and V\u00e9lez, I.D. (2019). Cutaneous leishmaniasis and co-morbid major depressive disorder: A systematic review with burden estimates. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007092"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpddr.2019.06.003","article-title":"Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis","volume":"11","author":"Caridha","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Mears, E.R., Modabber, F., Don, R., and Johnson, G.E. (2015). A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0003889"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fimmu.2012.00080","article-title":"T Helper1\/T Helper2 Cells and Resistance\/Susceptibility to Leishmania Infection: Is This Paradigm Still Relevant?","volume":"3","author":"Alexander","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_9","first-page":"32","article-title":"Does T Helper Differentiation Correlate with Resistance or Susceptibility to Infection with L. major? Some Insights from the Murine Model","volume":"3","author":"Weinkopff","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.4049\/jimmunol.174.5.2934","article-title":"Nonhealing Infection despite Th1 Polarization Produced by a Strain ofLeishmania majorin C57BL\/6 Mice","volume":"174","author":"Anderson","year":"2005","journal-title":"J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41580-020-0214-3","article-title":"The tubulin code and its role in controlling microtubule properties and functions","volume":"21","author":"Janke","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/14756360600700699","article-title":"Microtubule target for new antileishmanial drugs based on ethyl 3-haloacetamidobenzoates","volume":"21","author":"Hiam","year":"2006","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jid.2018.12.012","article-title":"TLR2 Signaling in Skin Nonhematopoietic Cells Induces Early Neutrophil Recruitment in Response to Leishmania major Infection","volume":"139","author":"Ronet","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1126\/science.1159194","article-title":"In Vivo Imaging Reveals an Essential Role for Neutrophils in Leishmaniasis Transmitted by Sand Flies","volume":"321","author":"Peters","year":"2008","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Hurrell, B.P., Schuster, S., Gr\u00fcn, E., Coutaz, M., Williams, R.A., Held, W., Malissen, B., Malissen, M., Yousefi, S., and Simon, H.-U. (2015). Rapid Sequestration of Leishmania mexicana by Neutrophils Contributes to the Development of Chronic Lesion. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004929"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fcimb.2014.00067","article-title":"A scoring method to standardize lesion monitoring following intra-dermal infection of Leishmania parasites in the murine ear","volume":"4","author":"Schuster","year":"2014","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3389\/fimmu.2017.01265","article-title":"Il-4ralpha Signaling in Keratinocytes and Early Il-4 Production Are Dispensable for Generating a Curative T Helper 1 Response in Leishmania Major-Infected C57bl\/6 Mice","volume":"8","author":"Descatoire","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1084\/jem.20061886","article-title":"CD4+CD25\u2212Foxp3\u2212 Th1 cells are the source of IL-10\u2013mediated immune suppression in chronic cutaneous leishmaniasis","volume":"204","author":"Anderson","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijpddr.2019.09.004","article-title":"Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis","volume":"11","author":"Jaafari","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.actatropica.2017.06.004","article-title":"Topical treatment with nanoliposomal Amphotericin B reduces early lesion growth but fails to induce cure in an experimental model of cutaneous leishmaniasis caused by Leishmania mexicana","volume":"173","author":"Varikuti","year":"2017","journal-title":"Acta Trop."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jtm.12089","article-title":"LeishMan Recommendations for Treatment of Cutaneous and Mucosal Leishmaniasis in Travelers, 2014","volume":"21","author":"Blum","year":"2014","journal-title":"J. Travel Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Aronson, N. (2017). Addressing a clinical challenge: Guidelines for the diagnosis and treatment of leishmaniasis. BMC Med., 15.","DOI":"10.1186\/s12916-017-0843-3"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4269\/ajtmh.1979.28.467","article-title":"Cutaneous Leishmaniasis\u2014A Case with Persistent Organisms after Treatment in Presence of Normal Immune Response","volume":"28","author":"Neva","year":"1979","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: Immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"10125","DOI":"10.1073\/pnas.0802331105","article-title":"Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies","volume":"105","author":"Kimblin","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/eji.201546015","article-title":"The Nlrp3 Inflammasome, Il-1beta, and Neutrophil Recruitment Are Required for Susceptibility to a Nonhealing Strain of Leishmania Major in C57bl\/6 Mice","volume":"46","author":"Charmoy","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1084\/jem.20171389","article-title":"Mannose receptor high, M2 dermal macrophages mediate nonhealing Leishmania major infection in a Th1 immune environment","volume":"215","author":"Lee","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2307\/3285646","article-title":"Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin","volume":"85","author":"Grogl","year":"1999","journal-title":"J. Parasitol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMoa1202657","article-title":"Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis","volume":"368","author":"Messaoud","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Sosa, N., Pascale, J.M., Jim\u00e9nez, A.I., Norwood, J.A., Kreishman-Detrick, M., Weina, P.J., Lawrence, K., McCarthy, W.F., Adams, R.C., and Scott, C. (2019). Topical paromomycin for New World cutaneous leishmaniasis. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007253"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/jphp.12548","article-title":"Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB\/c mouse model","volume":"68","author":"Yardley","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_32","first-page":"269","article-title":"Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis","volume":"12","author":"Eskandari","year":"2018","journal-title":"J. Arthropod. Borne Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40257-015-0114-z","article-title":"Cutaneous Leishmaniasis: Recent Developments in Diagnosis and Management","volume":"16","author":"Reedijk","year":"2015","journal-title":"Am. J. Clin. Dermatol."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/8\/11\/1803\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:34:26Z","timestamp":1760178866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/8\/11\/1803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["microorganisms8111803"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms8111803","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]}}}